IN2014DE01043A - - Google Patents

Download PDF

Info

Publication number
IN2014DE01043A
IN2014DE01043A IN1043DE2014A IN2014DE01043A IN 2014DE01043 A IN2014DE01043 A IN 2014DE01043A IN 1043DE2014 A IN1043DE2014 A IN 1043DE2014A IN 2014DE01043 A IN2014DE01043 A IN 2014DE01043A
Authority
IN
India
Prior art keywords
disclosed
compounds
inflammation
class
formula
Prior art date
Application number
Other languages
English (en)
Inventor
Neelima Goel
Suresh Kumar
Sandhya Bawa
Original Assignee
Neelima Goel
Suresh Kumar
Sandhya Bawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neelima Goel, Suresh Kumar, Sandhya Bawa filed Critical Neelima Goel
Priority to IN1043DE2014 priority Critical patent/IN2014DE01043A/en
Publication of IN2014DE01043A publication Critical patent/IN2014DE01043A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1043DE2014 2014-04-16 2014-04-16 IN2014DE01043A (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1043DE2014 IN2014DE01043A (https=) 2014-04-16 2014-04-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1043DE2014 IN2014DE01043A (https=) 2014-04-16 2014-04-16

Publications (1)

Publication Number Publication Date
IN2014DE01043A true IN2014DE01043A (https=) 2015-10-23

Family

ID=54395233

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1043DE2014 IN2014DE01043A (https=) 2014-04-16 2014-04-16

Country Status (1)

Country Link
IN (1) IN2014DE01043A (https=)

Similar Documents

Publication Publication Date Title
MX378145B (es) Formulaciones farmacéuticas tópicas que comprenden crisaborol para tratar afecciones inflamatorias
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
WO2015117081A3 (en) Methods and compositions for treatment of a beta thalessemia
ZA201604831B (en) Hybridosomes, compositions comprising the same, processes for their production and uses thereof
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
WO2015073587A3 (en) Synthetic membrane-receiver complexes
NZ720478A (en) Autotaxin inhibitor compounds
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
EP4193993A3 (en) Combinations of cannabinoids and n-acylethanolamines
SI3310389T1 (sl) Topični sestavki, ki obsegajo kortikosteroid in retinoid za zdravljenje psoriaze
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
EP3256438A4 (en) Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
MX2018006700A (es) Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4).
MX365494B (es) Procedimiento de compuesto antifungico.
EP3325608A4 (en) METHODS AND MICROORGANISMS FOR PRODUCING 1,3-BUTANEDIOL
WO2015191945A3 (en) Solid state forms of sofosbuvir
EP3122872A4 (en) Compositions and methods for treating type 1 and type 2 diabetes and related disorders
HK1243636A1 (zh) 用於治疗代谢疾病和癌症的新的线粒体解偶联剂
MX369357B (es) Procedimiento de compuesto antifungico.
MX2017001103A (es) Derivados de indolizina que son aplicables a enfermedades neurodegenerativas.
ZA201803476B (en) Anti-cd22 antibody-maytansine conjugates and methods of use thereof
JO3372B1 (ar) مشتقات 5-بنزيل إيزوكينولين لعلاج أمراض القلب والأوعية الدموية
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
SG10201900598TA (en) Factor viii formulation